Viewing Study NCT02750332


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-05-05 @ 4:40 PM
Study NCT ID: NCT02750332
Status: COMPLETED
Last Update Posted: 2017-03-15
First Post: 2016-04-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Bioavailability Food-Effect Study of an Oral Nitisinone Formulation to Treat Hereditary Tyrosinemia (HT-1)
Sponsor: Cycle Pharmaceuticals Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CT-002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View